NEWS
Phosphoenix and Insitute de la Vision (Sorbonne University) recieve EIC Transition grant
We’re proud to announce that we have won a highly competitive €2.5-million EIC Transition grant for our neural prosthesis project, SIGHTED, to develop and commercialise our brain implant for vision restoration. We are building on results from our preceding NeuraViPeR project, funded by Horizon 2020 FET-Open. With this generous support, we will accelerate progress toward our mission of enabling blind individuals to see again, together with our partner, the Institut de la Vision (Sorbonne University).
Phosphoenix sponsors GRC Neuroelectronics Interfaces Conference 2026
SIGHTED Project Kicks Off in Paris
The SIGHTED consortium met at the Institut de la Vision (IDV) in Paris on 8–9 July 2025 for the project's official kick-off meeting.
Partners presented the planned activities across the different work packages, aligned on next steps, and toured the IDV facilities. The meeting marked the start of an exciting collaboration focused on advancing neuroprosthetic technologies for vision restoration.
We are proud to sponsor the GRC Neuroelectronic Interfaces Conference, taking place on 8–13 February 2026 in Tuscany, Italy. The Neuroelectronic Interfaces GRC brings together researchers from around the world to share cutting-edge, unpublished work in neurotechnology, with a strong emphasis on discussion, collaboration, and community building across career stages. All members of our founding team — Pieter Roelfsema, Xing Chen, and Bert Monna — will be attending, with Pieter and Xing sharing updates on their latest research on visual prostheses.
Phosphoenix Featured in BiotechNews
Phosphoenix has been featured in the Spring 2026 edition of BiotechNews. The article highlights our mission to develop a next-generation visual neuroprosthesis for people with profound blindness and showcases the scientific and engineering innovations behind our technology, including the Fountain Probe™ and our approach to stimulating the lateral geniculate nucleus (LGN) of the brain. We thank BiotechNews for featuring our work and helping us share our vision with the wider biotechnology community.